Clinical Trials Directory

Trials / Completed

CompletedNCT00354510

Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis

Randomised, Double-blind, Placebo-controlled Study of Topical GW842470X Formulation in Adults With Moderate Atopic Dermatitis

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
190 (planned)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the clinical efficacy of 3% (w/w) GW842470X cream applied to involved skin of adult patients with moderate atopic dermatitis using the Eczema Area Severity Index (EASI) assessment of disease severity and to investigate the safety of and tolerability of 3% GW842470X cream on diseased skin of adult patients.

Conditions

Interventions

TypeNameDescription
DRUGGW842470X cream

Timeline

Start date
2006-03-01
First posted
2006-07-20
Last updated
2012-06-04

Locations

13 sites across 2 countries: Germany, Netherlands

Source: ClinicalTrials.gov record NCT00354510. Inclusion in this directory is not an endorsement.

Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis (NCT00354510) · Clinical Trials Directory